Alnylam Pharmaceuticals Inc. (ALNY) Fell -6.2% or -4.49 To Price $67.92 On Monday


Alnylam Pharmaceuticals Inc. (ALNY) fell -6.2% or -4.49 to $67.92. It is near 916492 shares traded, which is 101.97% compare to the average total volume 898766. The market cap of ALNY is $6.86 billion. The year to date change is -54.69%. The 52 week price range is from $67.69 to $153.99. Price of ALNY have changed -17.87% during last week. It have changed -8.69% over last month, -20.38% over last 3 months, -28.24% over last 6 months and -43.92% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALNY is 88.55. It is 30.37% above current price. The 200-day Moving Averages for ALNY is 103.35. It is 52.16% above current price. The 52-week High is 153.99. It is 126.72% from the current price. The 52-week Low is 67.69. It is -0.34% from current price.

There are some statistics of ALNY. It is has market cap $6.86 billion. The share outstanding is 101.03 million. The average volume is 898766. The revenue is 37.92M. The percent of top 15 Institution holding is 67.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALNY is -54.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALNY is -45.64%.


Tags:

Share this post